Status:
COMPLETED
Efficacy of Levetiracetam in Essential Tremor
Lead Sponsor:
Southern California Institute for Research and Education
Conditions:
Essential Tremor
Eligibility:
All Genders
25-85 years
Phase:
PHASE1
PHASE2
Brief Summary
Essential tremor poses one of the greatest therapeutic challenges to neurologists. This study will examine the effectiveness of the drug, levetiracetam or keppra, for the treatment of essential tremor...
Detailed Description
Currently available pharmacological treatments for essential tremor are hampered by relatively low efficacy and intolerable side effects. Recent evidence indicates that levetiracetam (LEV) may modulat...
Eligibility Criteria
Inclusion
- History of tremor for 5 or more years
- No other neurological problems
Exclusion
- Prior stroke or other neurological disease, psychiatric problems
- History of renal disease
- Pregnancy
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00620165
Start Date
January 1 2005
End Date
March 1 2008
Last Update
April 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Long Beach Healthcare System
Long Beach, California, United States, 90822